Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

DARPA and FDA Workshop on Preclinical Platforms for Evaluating Medical Countermeasure Efficacy and Toxicity

Solicitation Number: DARPA-SN-11-37
Agency: Other Defense Agencies
Office: Defense Advanced Research Projects Agency
Location: Contracts Management Office
  • Print
Special Notice
Added: May 20, 2011 8:28 am
The Defense Advanced Research Projects Agency (DARPA) Defense Sciences Office (DSO) and the U.S. Food and Drug Administration (FDA) Office of Chief Scientist (OCS) are hosting an informational workshop on June 21, 2011 at the Executive Conference Center (ECC) at Liberty Center in Arlington, VA. The purpose of the workshop is to discuss the scientific advancements that are needed, and the technical and regulatory challenges that must be overcome, for the development of human-relevant preclinical platforms for efficacy and toxicology testing.

See attached DARPA-SN-11-37
Please consult the list of document viewers if you cannot open a file.


Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Posted Date:
May 20, 2011
Description: DARPA-SN-11-37
3701 North Fairfax Drive
Arlington, Virginia 22203-1714
Barry Pallotta